We are live on ! Find out more
LP

LGL Partners Portfolio holdings

AUM $273M
1-Year Est. Return 24.15%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+24.15%
3 Year Est. Return
+68.92%
5 Year Est. Return
+65.82%
10 Year Est. Return
+206.18%
AUM
$273M
AUM Growth
+$30.5M
Cap. Flow
-$2.74M
Cap. Flow %
-1%
Top 10 Hldgs %
80.4%
Holding
73
New
7
Increased
40
Reduced
6
Closed
11

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.19M
2
LQDA icon
Liquidia Corp
LQDA
+$1.09M
3
CPNG icon
Coupang
CPNG
+$850K
4
SBRA icon
Sabra Healthcare REIT
SBRA
+$794K
5
JPM icon
JPMorgan Chase
JPM
+$615K

Sector Composition

Rank Sector Weight
1 Financials 0.82%
2 Technology 0.82%
3 Healthcare 0.45%
4 Industrials 0.36%
5 Communication Services 0.09%

No holdings matched the selected filter criteria.

Similar funds

LGL Partners's Q2 2026 Portfolio in Review

As of Q2 2026, LGL Partners held 73 positions worth $273M, up 13% from $243M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

LGL Partners's Q2 2026 filing shows 7 new, 40 increased, 6 reduced and 11 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 825 shares worth $567K. The largest sale was Eli Lilly, an estimated $1.19M.

By sector, the portfolio is most concentrated in Financials at 0.82% of assets, down from 1.1% a quarter earlier, followed by Technology and Healthcare.

  • LGL Partners's largest Q2 2026 buy was Vanguard S&P 500 ETF: 825 shares worth $567K.
  • LGL Partners added most to iShares Expanded Tech-Software Sector ETF in Q2 2026, an estimated $418K increase.
  • LGL Partners's biggest Q2 2026 reduction was Sabra Healthcare REIT, cutting an estimated $794K.
  • LGL Partners fully exited Eli Lilly in Q2 2026, selling an estimated $1.19M.
  • LGL Partners's ten largest holdings make up 80% of its $273M portfolio in Q2 2026.
  • LGL Partners opened 7 new positions and closed 11 in Q2 2026.
  • LGL Partners's portfolio value rose 13% quarter-over-quarter to $273M.

Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.